| Browse |
| Search |
| Future Titles |
 September 2008 Volume 1, Number 3 |
Cover Illustration: The cover illustration represents an artistic depiction of the results presented in the paper by Negri et.al. They demonstrate that TRK-A, HER-2 and KIT play a role in salivary gland carcinoma. |
TABLE OF CONTENTS
Original Report |
Gene therapy against murine melanoma B16F10-Nex2 using IL-13Ralpha2-Fc chimera and interleukin 12 in association with a cyclopalladated drug |
Flavia Hebeler-Barbosa, Elaine G Rodrigues, Rosana Puccia, Antonio C.F. Caires and Luiz R Travassos |
| Abstract Full Article |
TRK-A, HER-2/neu and KIT expression/activation profiles in salivary gland carcinoma |
Tiziana Negri, Elena Tamborini, Gian Paolo Dagrada, Angela Greco, Samantha Staurengo, Marco Guzzo, Laura D Locati, Antonino Carbone, Marco A Pierotti, Lisa Licitra and Silvana Pilotti |
| Abstract Full Article |
Proteasome inhibitor MG132 induces apoptosis and inhibits invasion of human malignant pleural mesothelioma cells |
Bao-Zhu Yuan, Joshua A. Chapman and Steven H. Reynolds |
| Abstract Full Article |
A phase II clinical trial of oral valproic acid (VPA) in patients with castration resistant prostate cancer (CRPCs) using an intensive biomarker sampling strategy. |
Sunil Sharma, James Symanowski, Bryan Wong, Pamela Dino, Phillip Manno and Nicholas Vogelzang |
| Abstract Full Article |
The novel retinoid, 9cUAB30, inhibits telomerase and induces apoptosis in HL60 cells |
William K Love, J. Tyson DeAngelis, Joel Berletch, Sharla M. Phipps, Lucy G. Andrews, Wayne J. Brouillette, Donald D. Muccio and Trygve O. Tollefsbol |
| Abstract Full Article |
Thioredoxin reductase 1 expression and castration-recurrentgGrowth of prostate cancer |
Swaroop Singh, Yun Li, Oscar H Ford, Carol S Wrzosek, Diana C Mehedint, Mark Titus and James L Mohler |
| Abstract Full Article |
| Home |
| Register |
| Submit Manuscript |
| Submit Review |
| Manuscript Status |
| FAQs |
| Contributor Instructions |
| Scope |
| Editorial Board |
| Subscribe |
| Contact Us |